Skip to main content

Table 1 The characteristics of samples

From: Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer

Clinical characteristics

Measure

Training data

Testing data

Number of samples

 

85

83

Number of samples in stage III

 

71

68

Number of samples in stage IV

 

14

15

 

min.

36

34

Ages (years old)

medium

58

59

 

max.

87

81

 

25th percentile

238

283.25

PFS (days)

median

396

458

 

75th percentile

618.25

684

Number of samples with censored observation

 

14

22

Treatment

 

paclitaxel carboplatin

paclitaxel carboplatin other drugs

  1. The clinical characteristics of the training samples and the testing samples.